# OnCo record mevpro-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/mevpro-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "mevpro-1", "NCT06551324" ;
  schema:name "MEVPRO-1"@en ;
  schema:description "MEVPRO-1 is the phase 3 trial of the first EZH2 inhibitor combination in prostate cancer."@en ;
  schema:url <https://onco.cc/trials/mevpro-1/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06551324> ;
  onco:status "active" ;
  onco:phase "3" ;
  schema:startDate "2024-10-21" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:targets <https://onco.cc/targets/ezh2/> ;
  onco:drugs <https://onco.cc/drugs/mevrometostat/>, <https://onco.cc/drugs/enzalutamide/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .